The company will use the funds to widen applications for its technology beyond moles and melanomas, and expand into new geographical markets.
Of the 206 respondents to the survey, 93% of whom were women, 63% said they strongly agreed with the safe and welcoming statement, while 24% somewhat agreed.
After the trial is completed, the company will produce a wearable device (iTBra), which will utilize a comfortable data collection device placed under a bra.
The setup involves a mini-microscope that attaches to a smartphone, an app and a HIPAA-compliant cloud-based analytical platform called DermEngine.
Polaris Health Directions and MD Anderson Cancer Center at Cooper are teaming-up to monitor patients' expected treatment response.
King's College Hospital will rely on Medopad's software to make it easier for patients to go through complicated treatment regimens.
Users should apply their blood sample in the designated spot, and let the device use a specialized microfluidic preparation system to extract a DNA sample.
Isaac Yonemoto's Project Marilyn is looking to raise $75,000 to use a compound sequenced from microscopic bug cultures to treat cancer.
The new funds will be used to expand development of the COTA platform, and hire new people to help launch the company's first commercial product.
The app is made to help those battling breast cancer keep track of their tests, submit information to clinical trials, access medical literature and more.